Introduction
Schizophrenia and bipolar I disorder are serious mental health conditions that can significantly affect thinking, mood, behavior, and daily functioning. Long-term treatment often includes medications that help manage symptoms while supporting overall stability and quality of life.
Lybalvi is an oral prescription medication that combines olanzapine, an established atypical antipsychotic, with samidorphan, an opioid receptor antagonist. The combination is designed to provide the therapeutic benefits of olanzapine while helping mitigate the weight gain commonly associated with olanzapine treatment, although clinically significant weight gain may still occur.
Because Lybalvi is a brand-name prescription medication, treatment costs can be substantial. Many people searching for a Lybalvi patient assistance program are looking for ways to reduce their prescription expenses. Prescription assistance programs, accessed through Prescription Hope, provide qualified patients with Lybalvi at an affordable rate.
What Is the Lybalvi Patient Assistance Program?
Understanding Lybalvi Prescription Assistance
With the high cost of specialty medications, patients often search for affordable Lybalvi or Lybalvi savings programs.
Manufacturers understand that patients searching for medications like these need financial relief for the high cost of medications. Therefore, many manufacturers offer patient assistance programs to help qualified patients offset the cost of the medication.
These programs provide affordable medications to qualified patients. However, many of them are difficult to navigate, which leaves patients frustrated when applying on their own.
How Expert Advocates Help Make Lybalvi More Affordable
Personalized Medication Assistance
Are you looking for trusted prescription assistance specialists? Look no further; at Prescription Hope, our patient support services take care of the application process for patient assistance programs, from start to finish.
Our dedicated team of patient support specialists manages form completion, document and signature collection, coordination with healthcare providers and manufacturers, and all the minutiae that come with applying for patient assistance programs.
Ongoing Patient Support
At Prescription Hope, our services don’t end at application assistance; we also offer long-term medication assistance. Our team manages all the administrative tasks such as form and document updates, issue resolution, program monitoring, yearly renewals, and even scheduling refills.
Lybalvi Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Schizophrenia and Bipolar I Disorder Treatment Costs
While schizophrenia and bipolar disorder medications can be extremely expensive, medication cost assistance through Prescription Hope can make all the difference.
For $70.00 per month, per medication, patients get access to specialty schizophrenia and bipolar disorder medication assistance without any hidden charges or fees, variable pricing systems, or medication costs.
Lybalvi Patient Assistance Eligibility
General Eligibility Requirements
While determining specific Lybalvi patient assistance qualifications is best done by enrolling with Prescription Hope, it’s good to understand general prescription assistance requirements.
They include:
Income: Each program maintains its own income threshold.
Insurance: Each program maintains its own requirement regarding insurance coverage status.
Prescription: All qualified patients must have a valid prescription for their brand- name medication that they wish to apply for.
U.S. Residency: All qualified patients must have legal U.S. residency.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Patients who are ready to enroll in prescription assistance can enroll with Prescription Hope today. Enrolling with Prescription Hope only takes six steps:
- Submit Information: Our online form can be completed in just a few minutes.
- Advocate Contact: A patient advocate will contact you within 2 business days.
- Document Collection: Following a quick prequalification, our team will collect needed documents.
- Provider Coordination: We connect with your healthcare provider to secure vital signatures.
- Program Submission: Our team completes your application packet, submits it, and continues to follow up with the manufacturer.
- Medication Delivery: Once approved, qualified patients can typically expect to receive their medication within 2 weeks, though shipping times may vary. All medication shipments arrive directly from the manufacturer to your home or doctor’s office.
Understanding Lybalvi
How Lybalvi Works
Lybalvi contains two medications that work together:
- Olanzapine helps balance dopamine and serotonin activity in the brain, improving symptoms such as hallucinations, delusions, mood changes, and disorganized thinking.
- Samidorphan is an opioid receptor antagonist that has been shown to mitigate olanzapine-associated weight gain in many patients, although clinically significant weight gain may still occur.
Together, the two medications provide the therapeutic benefits of olanzapine while helping reduce one of its most significant long-term metabolic side effects.
What Conditions Does Lybalvi Treat?
Lybalvi is FDA-approved for the treatment of:
Schizophrenia
- Treatment of schizophrenia in adults
Bipolar I Disorder
- Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy or adjunctive therapy to lithium or valproate
- Maintenance monotherapy of bipolar I disorder in adults
Benefits of Treatment
For appropriate patients, Lybalvi may:
- Reduce hallucinations and delusions associated with schizophrenia.
- Improve mood stability during manic or mixed episodes of bipolar I disorder.
- Help maintain long-term symptom control in bipolar I disorder.
- Improve overall daily functioning by controlling psychiatric symptoms.
- May reduce olanzapine-associated weight gain compared with olanzapine alone, although clinically significant weight gain can still occur
- Offer the convenience of a single-tablet combination medication.
Individual treatment responses vary, and ongoing psychiatric follow-up is important.
Important Safety Information and Side Effects
Lybalvi carries two FDA Boxed Warnings.
Increased Mortality in Elderly Patients with Dementia-Related Psychosis
Lybalvi carries an FDA Boxed Warning because elderly patients with dementia-related psychosis treated with antipsychotic medications have an increased risk of death.
It is not approved for the treatment of patients with dementia-related psychosis.
Risk of Severe Opioid Withdrawal
Because samidorphan blocks opioid receptors:
- Lybalvi is contraindicated in patients currently using opioids or undergoing acute opioid withdrawal.
- Starting Lybalvi in these patients may precipitate severe opioid withdrawal requiring hospitalization.
- Patients must complete an adequate opioid-free interval before beginning treatment.
The most commonly reported side effects include:
- Weight gain
- Sleepiness (somnolence)
- Dry mouth
- Increased appetite
- Dizziness
- Constipation
- Tremor
- Fatigue
- Increased salivation
Laboratory abnormalities may include:
- Elevated blood sugar
- Increased cholesterol and triglycerides
- Elevated liver enzymes
- Increased prolactin levels in some patients
Patients should discuss the following risks with their healthcare provider:
- High blood sugar (hyperglycemia) and diabetes
- Elevated cholesterol and triglycerides
- Weight gain
- Neuroleptic malignant syndrome (NMS)
- Tardive dyskinesia
- Orthostatic hypotension and falls.
- Seizures
- Difficulty regulating body temperature
- Low white blood cell counts (leukopenia/neutropenia)
- Liver function abnormalities
- Difficulty swallowing (dysphagia)
- Cognitive and motor impairment
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
- Severe constipation and rare gastrointestinal complications
Important Opioid Safety Information
Because samidorphan blocks opioid receptors:
- Patients must not use opioid-containing medications while taking Lybalvi.
- Patients should inform all healthcare providers that they are taking this medication before receiving pain medications or undergoing surgery.
- Patients should carry information indicating they are taking a medication containing samidorphan.
- Patients should never attempt to overcome opioid receptor blockade by taking large amounts of opioids, as this may result in life-threatening or fatal opioid overdose.
Exposure to antipsychotic medications during the third trimester may cause extrapyramidal symptoms (EPS) and/or withdrawal symptoms in newborns. Patients who are pregnant or planning to become pregnant should discuss treatment with their healthcare provider. Neonates exposed during the third trimester should be monitored after birth, and enrollment in the National Pregnancy Registry for Atypical Antipsychotics may be recommended.
Breastfeeding is not recommended because olanzapine passes into breast milk and may affect the nursing infant.
Lybalvi may interact with:
- All opioid-containing medications (contraindicated)
- Benzodiazepines and other central nervous system depressants
- Alcohol
- Tobacco smoking
- Strong CYP1A2 inducers
- Antihypertensive medications
- Dopamine agonists (such as levodopa)
- Other medications that prolong sedation or impair alertness
Patients should inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before starting treatment.
Lybalvi is taken orally once daily and may be taken with or without food. Tablets should be swallowed whole and should not be split, crushed, or chewed. Patients must not use opioids while taking this medication. Treatment is prescribed and monitored by psychiatrists or other qualified mental health providers, with regular monitoring of weight, blood glucose, lipid levels, and movement disorders.
Access to Multiple Medications
Support Beyond Lybalvi
Are you looking for schizophrenia or bipolar disorder medication support as well as other specialty medication access?
Prescription Hope routinely helps qualified patients access multiple medication assistance programs at once. Whether one or many, our dedicated team provides all services for a simple $70.00 per month, per medication.
Why Choose Prescription Hope
Patient-Focused Medication Support
For two decades, patients with Prescription Hope have received patient-centered assistance and support that provides them with prescription affordability support. Our Florida-based medication access specialists can provide brand-name medication assistance through Prescription Hope.
Simplified Access to Prescription Medications
At Prescription Hope, our schizophrenia and bipolar disorder medication access and prescription assistance helps provide qualified patients with the support they need to lower their medication costs and have peace of mind when it comes to prescription medication prices.
Ongoing Prescription Assistance
Prescription Hope not only offers help with mental health treatment support, but we also provide long-term medication support. Our dedicated team of patient advocates takes care of form and document updates, issue resolution, yearly renewals, program monitoring, and even refill scheduling.
If you need access to affordable brand-name medications like Lybalvi, then enroll with Prescription Hope today!